295 reports of suspected side effects of implants in 2023 In 2023, 295 individuals reported one or more suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI).
Growth of digital healthcare stabilised in 2023 The growth in the use of digital healthcare tools by care providers stabilised in 2023. This was mainly because most care providers were already using particular digital tools in 2022, such as the patient portal – on which patients can view the outcomes of examinations – and e-consultations (digital written contact with doctors).
RIVM identifies three major challenges for public health and healthcare in period to 2050 The Dutch public health and healthcare will face three crucial challenges in the period to 2050. This is according to RIVM’s preview of the Dutch Public Health Foresight Study 2024.
New version of NEVO with updated data on meat and dairy substitutes Today, RIVM will publish the new version of the Dutch Food Composition Database (Nederlands Voedingsstoffenbestand, NEVO). This contains information on the composition of more than 2,300 foods.
Breast implants can cause health problems even five years or more after placement Over the past 5 years, the Dutch reporting and expertise centre for adverse effects of medical implants (MEBI) has received 977 reports of health problems related to breast implants. An analysis by RIVM has shown that 39% of the reported health problems started 5 or more years after the implant’s placement.
No indication that investigated mesh implants used to treat pelvic organ prolapse are unsafe RIVM has conducted a laboratory study into six mesh implants from different manufacturers used in the Netherlands in 2018. The study revealed no indication that these products are unsafe for patients.
Hypersensitivity reactions to fillers may occur after COVID-19 vaccination People may experience hypersensitivity reactions to fillers following a COVID-19 vaccination.
BA.2.75 variant found in the Netherlands The BA.2.75 variant of the coronavirus SARS-CoV-2 has now also been found in the Netherlands. The variant was detected in a sample from 26 June 2022 taken in the region of Noordoost-Gelderland.
Antibiotic use and antimicrobial resistance remain stable Antibiotic resistance in the Netherlands remained stable in 2021 compared with the five previous years. This is evident from the 2022 annual NethMap/MARAN report.
SARS-CoV-2 infections continue to rise Infections with the coronavirus SARS-CoV-2 in the Netherlands continued to rise this week. This increase can be seen in sewage surveillance and in the infections reported to the Municipal Public Health Services (GGDs).